Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(6 sites)

United States

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Icahn School of Medicine at Mount Sinai, New York, New York

Cleveland Clinic Foundation, Cleveland, Ohio

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

Vanderbilt University Medical Center, Nashville, Tennessee

Texas Cardiac Arrhythmia Research Foundation, Austin, Texas